002873.SZ

Guiyang Xintian Pharmaceutical Co.,Ltd. [002873.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

002873.SZ Stock Summary

In the News

002873.SZ Financial details

Company Rating
Buy
Market Cap
2.97B
Income
98.93M
Revenue
994.1M
Book val./share
4.81
Cash/share
0.82
Dividend
0.1
Dividend %
0.83%
Employees
929
Optionable
No
Shortable
Yes
Earnings
27 Apr 2024
P/E
30.15
Forward P/E
13.59
PEG
-131.35
P/S
2.85
P/B
2.49
P/C
15.41
P/FCF
-46.79
Quick Ratio
0.97
Current Ratio
1.25
Debt / Equity
0.56
LT Debt / Equity
0.17
-
-
EPS (TTM)
0.43
EPS next Y
0.93
EPS next Q
-
EPS this Y
13.64%
EPS next Y
116.33%
EPS next 5Y
116.33%
EPS last 5Y
10.03%
Revenue last 5Y
9.39%
Revenue Q/Q
-21.25%
EPS Q/Q
96.51%
-
-
-
-
SMA20
46.61%
SMA50
7.86%
SMA100
10.94%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
9%
ROC
0.08%
Gross Margin
77%
Oper. Margin
11%
Profit Margin
10%
Payout
41%
Shs Outstand
227.58M
Shs Float
227.05M
-
-
-
-
Target Price
-
52W Range
7.59-15.38
52W High
-15.73%
52W Low
+80.57%
RSI
57.03
Rel Volume
0.43
Avg Volume
5.54M
Volume
2.38M
Perf Week
-9.78%
Perf Month
20.96%
Perf Quarter
-
Perf Half Y
4.55%
-
-
-
-
Beta
-0.165
-
-
Volatility
0.5%, 1.9%
Prev Close
1.2%
Price
12.64
Change
-1.94%

002873.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.053.423.113.974.69
Net income per share
0.310.320.30.410.48
Operating cash flow per share
0.210.150.730.510.33
Free cash flow per share
0.03-0.540.450.08-0.23
Cash per share
0.610.81.860.620.43
Book value per share
2.893.123.433.644.87
Tangible book value per share
2.512.612.893.084.23
Share holders equity per share
2.893.123.433.644.87
Interest debt per share
0.951.152.361.832.14
Market cap
1.84B1.95B2B3.53B3.36B
Enterprise value
1.92B2.02B2.24B3.89B3.74B
P/E ratio
25.9927.2727.5935.4730.11
Price to sales ratio
2.662.522.673.643.09
POCF ratio
38.7557.7411.3928.3944.29
PFCF ratio
261.57-15.9218.6189.61-62.9
P/B Ratio
2.82.752.423.962.97
PTB ratio
2.82.752.423.962.97
EV to sales
2.762.612.984.013.44
Enterprise value over EBITDA
18.9818.620.4824.4122.99
EV to operating cash flow
40.359.912.7231.2649.37
EV to free cash flow
271.99-16.5120.78208.82-70.12
Earnings yield
0.040.040.040.030.03
Free cash flow yield
0-0.060.050.01-0.02
Debt to equity
0.320.360.680.480.43
Debt to assets
0.220.230.370.280.26
Net debt to EBITDA
0.730.672.152.252.37
Current ratio
2.11.771.581.331.23
Interest coverage
24.8512.5515.797.0511.44
Income quality
0.680.482.371.240.65
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.310.230.360.30.31
Sales general and administrative to revenue
0.080.070.060.060.04
Research and developement to revenue
0.050.030.020.020.02
Intangibles to total assets
0.090.110.090.090.08
Capex to operating cash flow
-0.85-4.63-0.39-0.85-1.7
Capex to revenue
-0.06-0.2-0.09-0.11-0.12
Capex to depreciation
-2.99-9.75-3.57-4.63-5.08
Stock based compensation to revenue
00.010.0100.01
Graham number
4.514.714.825.777.26
ROIC
0.070.070.050.080.07
Return on tangible assets
0.080.070.050.070.07
Graham Net
0.240.36-0.04-0.76-1.22
Working capital
329.49M257.36M299.24M145.59M115.24M
Tangible asset value
570.74M590.98M696.35M752.75M980.05M
Net current asset value
304.58M215.17M105.24M-47.15M-100.66M
Invested capital
0.320.360.680.480.43
Average receivables
233.45M284.7M289.42M294.46M316.6M
Average payables
36.36M36.56M37.79M54.85M80.28M
Average inventory
74.37M88.13M90.43M102.8M151.06M
Days sales outstanding
139.43143.58133.49118.28107.02
Days payables outstanding
106.169.0998.93117.75141.21
Days of inventory on hand
205.94211.12191.68215.51270.62
Receivables turnover
2.622.542.733.093.41
Payables turnover
3.445.283.693.12.58
Inventory turnover
1.771.731.91.691.35
ROE
0.110.10.090.110.1
Capex per share
-0.18-0.69-0.28-0.43-0.56

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.960.940.851.291.01
Net income per share
0.270.050.10.090.17
Operating cash flow per share
0.270.050.1-0.060.2
Free cash flow per share
0.13-0.06-0.04-0.160.15
Cash per share
0.510.430.470.520.82
Book value per share
5.744.874.74.714.81
Tangible book value per share
4.94.224.074.064.16
Share holders equity per share
5.744.874.74.714.81
Interest debt per share
2.422.122.242.552.72
Market cap
1.84B3.36B3.38B3.32B3.18B
Enterprise value
2.18B3.75B3.81B3.81B3.64B
P/E ratio
9.7274.9133.6939.0419.19
Price to sales ratio
5.3515.3816.210.4612.72
POCF ratio
38.88299.64134.77-233.5762.69
PFCF ratio
78.31-260.47-365.45-84.5585.19
P/B Ratio
1.832.982.932.872.66
PTB ratio
1.832.982.932.872.66
EV to sales
6.3217.1518.2712.0214.59
Enterprise value over EBITDA
39.57426.52125.76107.1669.92
EV to operating cash flow
45.91334.01151.96-268.4471.93
EV to free cash flow
92.47-290.35-412.06-97.1797.74
Earnings yield
0.0300.010.010.01
Free cash flow yield
0.0100-0.010.01
Debt to equity
0.420.430.470.540.56
Debt to assets
0.260.260.290.310.32
Net debt to EBITDA
6.0643.914.2313.928.97
Current ratio
1.461.231.211.231.25
Interest coverage
15.370.996.978.4711.17
Income quality
111-0.671.22
Dividend Yield
0.01000.010
Payout ratio
0.480.480.141.280.11
Sales general and administrative to revenue
0.23-0.240.13-0.020.36
Research and developement to revenue
0.010.040.020.030.04
Intangibles to total assets
0.090.080.080.080.08
Capex to operating cash flow
-0.5-2.15-1.371.76-0.26
Capex to revenue
-0.07-0.11-0.16-0.08-0.05
Capex to depreciation
-3.84-3.88-5.97-4.351.29
Stock based compensation to revenue
-0.020.0500.01-0.01
Graham number
5.92.33.293.034.25
ROIC
0.030.010.010.010.02
Return on tangible assets
0.030.010.010.010.02
Graham Net
-0.98-1.22-1.21-1.31-1.16
Working capital
198.8M115.24M110.03M128.49M155.49M
Tangible asset value
863.41M980.05M1B996.9M1.03B
Net current asset value
1.47M-100.66M-108.24M-131.53M-102.55M
Invested capital
0.420.430.470.540.56
Average receivables
350.29M357.12M310.92M345.63M392.68M
Average payables
67.65M79.29M91.52M85.29M85.88M
Average inventory
158.64M166.74M197.02M194.48M174.3M
Days sales outstanding
103.22131.4130.6110.2143.07
Days payables outstanding
70.29160.37171.73100.46139.75
Days of inventory on hand
167.72307.34414.14215.22268.81
Receivables turnover
0.870.680.690.820.63
Payables turnover
1.280.560.520.90.64
Inventory turnover
0.540.290.220.420.33
ROE
0.050.010.020.020.03
Capex per share
-0.14-0.1-0.14-0.1-0.05

002873.SZ Frequently Asked Questions

What is Guiyang Xintian Pharmaceutical Co.,Ltd. stock symbol ?

Guiyang Xintian Pharmaceutical Co.,Ltd. is a CN stock and trading under the symbol 002873.SZ

What is Guiyang Xintian Pharmaceutical Co.,Ltd. stock quote today ?

Guiyang Xintian Pharmaceutical Co.,Ltd. stock price is $12.64 today.

Is Guiyang Xintian Pharmaceutical Co.,Ltd. stock public?

Yes, Guiyang Xintian Pharmaceutical Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap